Article citationsMore>>

Vareesangthip, K., Deerochanawong, C., Thongsuk, D., Pojchaijongdee, N. and Permsuwan, U. (2022) Cost-Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand. Advances in Therapy, 39, 1279-1292.
https://doi.org/10.1007/s12325-021-02037-6

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top